`
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Interleukin-2 (IL-2) stimulates the
expansion of cytotoxic CD8+ T cells via
the intermediate-affinity 2-chain (β,γ) receptor.
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Interleukin-2 (IL-2) is a cytokine whose action
is mediated via:
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Interleukin-2 (IL-2) receptors (either intermediate-affinity
or high-affinity) are found on various types of
immune cells including:
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Which of the following about the tumor effects of interleukin-2 (IL-2) is correct:
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Which of the following cells are associated with cytotoxic
anti-tumor effects?
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Drag the immune cell labels onto the correct
blue tile based on their role in cancer.
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Drag and drop the cells onto the correct images based on the
type of interleukin-2 (IL-2) receptor they predominantly express.
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Match the correct statements:
Select a blue tile and a matching green tile to correctly complete the statement
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Identify where IL-2 and PD-1/PD-L1 pathways
play a role in the cancer immunity cycle.
Select 2 stages to answer
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Which of the following cell types are associated with immunosuppressive effects?
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Antigen-presenting cells (APCs) are a heterogeneous group
of immune cells that mediate the cellular immune response by:
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
What are the three main types of antigen-presenting cells?
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Match the cytotoxic effector cell with the type of
immunity with which it is most commonly associated:
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Upon secretion, interleukin-12 and -18 (IL-12, IL-18) can potentially
stimulate NK and T cells to drive production of which interferon?
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Interferon-γ can have a variety of anti-tumor benefits
that include which of the following?
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Match the cell type and cytokine with the type of
cancer-immunity processes with which it is primarily associated:
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
Binding of IL-2 to the intermediate-affinity 2-chain
IL-2 receptor would be expected to:
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
The effects of the PD-1/PD-L1 pathway on the immune system are:
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.
The quiz is complete.
Thank you for participating. Your final score was
0/0
Mural Oncology is a trademark of Mural Oncology, plc.
© 2023 Mural Oncology, plc. All rights reserved.